FEATURED/ARCHIVES (04/05/24)
An Update in the Prevention of Psychosis Spectrum Disorders · May 2018
Articles
Papeles del Psicologo
Chronic Treatment with Aripiprazole Prevents Development of Dopamine Supersensitivity and Potentially Supersensitivity Psychosis · March 2011
Articles
Schizophrenia Bulletin
Physicians’ and Patients’ Involvement in Relapse Prevention with Antipsychotics in Schizophrenia · November 2005
Articles
Psychiatric Services
Preventive Pharmacological Treatment: An Evolving New Concept in Schizophrenia · April 2011
Articles
NCBI>Israel Journal of Psychiatry and Related Sciences
Omega-3 Fatty Acid Supplementation May Prevent Loss of Gray Matter Thickness in the Left Parieto-Occipital Cortex in First Episode Schizophrenia: A Secondary Outcome Analysis of the OFFER Randomized Controlled Study · November 2017
Abstracts
Schizophrenia Research
Long-Acting Injectable Paliperidone Palmitate versus Oral Paliperidone Extended Release: A Comparative Analysis from Two Placebo-Controlled Relapse Prevention Studies · July 2013
Articles
Annals of General Psychiatry
Long-Acting Injectable Antipsychotics for Prevention and Management of Violent Behaviour in Psychotic Patients · September 2017
Abstracts
International Journal of Clinical Practice
Digital Smartphone Intervention to Recognise and Manage Early Warning Signs in Schizophrenia to Prevent Relapse: The EMPOWER Feasibility Cluster RCT · May 2022
Publications (Books-Reports)
National Institute for Health and Care Research
Low Dose vs Standard Dose of Antipsychotics for Relapse Prevention in Schizophrenia: Meta-Analysis · November 2009
Articles
Schizophrenia Bulletin
Effectiveness of Family Intervention for Preventing Relapse in First-Episode Psychosis Until 24 Months of Follow-Up: A Systematic Review with Meta-Analysis of Randomized Controlled Trials · May 2019
Articles
Schizophrenia Bulletin
Tailored Intervention to Prevent Relapses and Hospitalization in a Migrant Suffering from Paranoid Schizophrenia · June 2021
Articles
Oxford Medical Case Reports
Long-Acting Injectable Risperidone for Relapse Prevention and Control of Breakthrough Symptoms After a Recent First Episode of Schizophrenia: A Randomized Clinical Trial · August 2015
Articles
JAMA Psychiatry
Can Perinatal Supplementation of Long-Chain Polyunsaturated Fatty Acids Prevents Schizophrenia in Adult Life? · December 2004
Articles
Medical Science Monitor
Effectiveness of a Combined Therapy of Long-Acting Injectable Risperidone and Psychosocial Intervention for Relapse Prevention in Patients with Schizophrenia · February 2008
Articles
Clinical Psychopharmacology and Neuroscience
Long-Term Cariprazine Treatment for the Prevention of Relapse in Patients with Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial · July 2016
Articles
Schizophrenia Research
Cognitive Therapy for the Prevention of Psychosis in People at Ultra-High Risk: Randomised Controlled Trial · October 2004
Articles
British Journal of Psychiatry
Shared Biological Pathways between Antipsychotics and Omega-3 Fatty Acids: A Key Feature for Schizophrenia Preventive Treatment? · June 2021
Articles
International Journal of Molecular Sciences
Lack of Evidence to Favor Specific Preventive Interventions in Psychosis: A Network Meta-Analysis · May 2018
Articles
World Psychiatry
The Prevention of Schizophrenia: What Interventions Are Safe and Effective? · October 2001
Articles
Schizophrenia Bulletin